1. Home
  2. FSP vs SAVA Comparison

FSP vs SAVA Comparison

Compare FSP & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.75

Market Cap

94.6M

Sector

Real Estate

ML Signal

HOLD

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.45

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
SAVA
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.6M
96.1M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
FSP
SAVA
Price
$0.75
$2.45
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
549.6K
598.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$120,112,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$0.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$1.15
52 Week High
$1.96
$4.98

Technical Indicators

Market Signals
Indicator
FSP
SAVA
Relative Strength Index (RSI) 37.85 52.95
Support Level $0.75 $1.97
Resistance Level $0.86 $2.27
Average True Range (ATR) 0.05 0.11
MACD 0.00 0.03
Stochastic Oscillator 21.08 88.57

Price Performance

Historical Comparison
FSP
SAVA

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: